Kimberly A. Witzmann

Pediatric Pulmonology

10903 New Hampshire Ave
Silver Spring, MD 20993

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7 publications

Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.

Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.

Journal: Molecular pharmaceutics

Published: September 29, 2023

Analytical method development for characterizing ingredient-specific particle size distributions of nasal spray suspension products.

Analytical method development for characterizing ingredient-specific particle size distributions of nasal spray suspension products.

Journal: Journal of pharmaceutical sciences

Published: January 19, 2021

A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.

A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.

Journal: Journal of clinical pharmacology

Published: May 06, 2020

Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products.

Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products.

Journal: Pharmaceutical medicine

Published: March 01, 2020

Generic drug device combination products: Regulatory and scientific considerations.

Generic drug device combination products: Regulatory and scientific considerations.

Journal: International journal of pharmaceutics

Published: August 24, 2017

Response.

Response.

Journal: Chest

Published: October 02, 2013

Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.

Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.

Journal: Chest

Published: January 02, 2013

Showing 1-7 of 7

Last Updated: 09/26/2026